A1 Refereed original research article in a scientific journal
Iron Overload in Allogeneic Hematopoietic Cell Transplantation Outcome: A Meta-Analysis
Authors: Philippe Armand, Haesook T. Kim, Johanna M. Virtanen, Riitta K. Parkkola, Maija A. Itälä-Remes, Navneet S. Majhail, Linda J. Burns, Todd DeFor, Bryan Trottier, Uwe Platzbecker, Joseph H. Antin, Martin Wermke
Publisher: Elsevier Inc.
Publication year: 2014
Journal: Biology of Blood and Marrow Transplantation
Journal name in source: Biology of Blood and Marrow Transplantation
Volume: 20
Issue: 8
First page : 1248
Last page: 1251
Number of pages: 4
ISSN: 1523-6536
DOI: https://doi.org/10.1016/j.bbmt.2014.04.024
Web address : http://api.elsevier.com/content/abstract/scopus_id:84904065494
An elevated ferritin level before allogeneic hematopoietic cell transplantation (HCT) is an adverse prognostic factor for overall survival (OS) and nonrelapse mortality. Because ferritin is an imperfect surrogate of iron stores, the prognostic role of iron overload remains unclear. We conducted a patient-level meta-analysis of 4studies that used magnetic resonance imaging to estimate pre-HCT liver iron content (LIC). An elevated LIC was not associated with a significant increase in mortality: the hazard ratio (HR) for mortality associated with LIC>7mg/g dry weight (primary endpoint) was 1.4 (P= .18). In contrast, ferritin >1000ng/mL was a significant prognostic factor (HR for mortality, 1.7; P= .036). There was, however, no significant association between ferritin > 2500 and mortality. This meta-analysis suggests that iron overload, as assessed by LIC, is not a strong prognostic factor for OS in a general adult HCT population. Our data also suggest that ferritin is an inadequate surrogate for iron overload in HCT. © 2014 American Society for Blood and Marrow Transplantation.